Visitor contact precautions, or VCPs, a common bulwark against Clostridium difficile in the elderly, may make very little difference in infections when compared with small changes in normal daily ...

C. diff is a horrible disease that can cause significant morbidity. It can and often does recur and kills around 30,000 Americans every year. We have made progress in prevention and treatment, but ...

Background. Contact Precautions are recommended by health authorities in Europe and the United States for patients with Clostridium difficile infection (CDI). Recently, the significance of nosocomial ...

A multifaceted approach focused on enforcing basic infection prevention practices and promoting education about Clostridioides difficile (C difficile) transmission led to a reduction in the number of ...

Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, and kills up to 30,000. It is a leading cause of health-care-associated ...

Amid National C. Diff Awareness Month, Christian John Lillis, cofounder and executive director of the Peggy Lillis Foundation for C. Diff Education & Advocacy, explains the foundation's "See C. diff" ...

One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times more than previously thought, new research has found. There's a lot going on ...

Vowst (fecal microbiota spores, live-brpk) is a brand-name oral capsule that’s prescribed to help prevent Clostridioides difficile (C. diff) infection returning after antibiotic treatment in certain ...

The pathogen C. diff—the most common cause of health care-associated infectious diarrhea—can use a compound that kills the human gut's resident microbes to survive and grow, giving it a competitive ...

Ten days after Finch Therapeutics let go 20% of its workforce, the winds have changed. The FDA has lifted a clinical hold on the biotech’s donor-derived microbiome drug for Clostridioides difficile, ...